Harmony Biosciences Holdings (HRMY) Net Cash Flow (QoQ) (2020 - 2026)
Harmony Biosciences Holdings (HRMY) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254.60% |
| Dec 31, 2025 | 4.51% |
| Sep 30, 2025 | 76.94% |
| Jun 30, 2025 | 58.49% |
| Mar 31, 2025 | -45.15% |
| Dec 31, 2024 | -6.33% |
| Sep 30, 2024 | 546.74% |
| Jun 30, 2024 | -173.57% |
| Mar 31, 2024 | 264.98% |
| Dec 31, 2023 | -279.79% |
| Sep 30, 2023 | -75.17% |
| Jun 30, 2023 | -34.46% |
| Mar 31, 2023 | 351.60% |
| Dec 31, 2022 | -170.77% |
| Sep 30, 2022 | 106.17% |
| Jun 30, 2022 | 222.67% |
| Mar 31, 2022 | -121.99% |
| Dec 31, 2021 | 48.59% |
| Sep 30, 2021 | 62.11% |
| Jun 30, 2021 | 121.17% |